Sine oculis homeobox protein 1 (SIX1)

Sine oculis homeobox protein 1 (SIX1) is a transcription factor belonging to the highly conserved Six family. It plays crucial roles in regulating organ development during embryogenesis, notably in the kidney, ear, craniofacial region, muscle, and immune system tissues[3][4][5][7][8]. SIX1 forms a bipartite transcription complex with EYA proteins, governing gene expression essential for organogenesis and cell fate. In adult tissues, reactivation of SIX1 is closely associated with malignancy, acting as a potent oncogene that promotes cell proliferation, represses cellular senescence (a tumor-suppressive program), induces stem-like phenotypes (through SOX2), reprograms metabolism, and contributes to tumor immunosuppression by modulating collagen gene expression[1][2][3][5][8]. Mutations in SIX1 lead to developmental syndromes such as branchio-oto-renal syndrome, and its dysregulation is implicated in several cancers and congenital anomalies[7][8]. As a molecular target, it is under investigation for therapeutic intervention in cancer, with research focusing on disrupting its disease-associated protein-protein interactions[3].

Other names

Sine oculis homeobox 1SIX1 homeoproteinSine oculis homolog 1 (Drosophila)SOHLH1sine oculis–related homeobox 1

Potential mechanisms for drugs (mostly experimental) include: - Disruption of SIX1–EYA interaction to inhibit metastasis and progression - Modulation of transcriptional activity to restore tumor suppressive functions or block oncogenic gene expression